Leadership
The Gilead Leadership Team and Board of Directors provide the necessary guidance to execute our mission and realize our vision.
-
Daniel O’Day
Chairman and Chief Executive Officer, Gilead Sciences, Inc.
-
Andrew Dickinson
Chief Financial Officer
-
Flavius Martin
Executive Vice President, Research
-
Jyoti Mehra
Executive Vice President, Human Resources
-
Johanna Mercier
Chief Commercial Officer
-
Merdad Parsey, MD, PhD
Chief Medical Officer
-
Brett A. Pletcher
Executive Vice President, Corporate Affairs and General Counsel
-
Christi Shaw
Chief Executive Officer, Kite
-
Taiyin Yang, PhD
Executive Vice President, Pharmaceutical Development and Manufacturing
-
Daniel O’Day
Chairman and Chief Executive Officer
-
Jacqueline K. Barton, PhD
Professor, California Institute of Technology
-
Jeffrey A. Bluestone, PhD
President and Chief Executive Officer, Sonoma Biotherapeutics; A.W. and Mary Margaret Clausen Distinguished Professor in the Diabetes Center at University of California San Francisco
-
Sandra J. Horning, MD
Retired, Chief Medical Officer, Roche, Inc.; Emerita Professor, Stanford University
-
Kelly A. Kramer
Retired, Executive Vice President and Chief Financial Officer, Cisco Systems, Inc.
-
Kevin E. Lofton
Lead Independent Director; Retired Chief Executive Officer, CommonSpirit Health
-
Harish Manwani
Retired Chief Operating Officer, Unilever
-
Javier J. Rodriguez
Chief Executive Officer, DaVita Inc.
-
Anthony Welters
Retired, Senior Advisor to the Office of CEO, UnitedHealth Group; Executive Chairman, BlackIvy Group, LLC